These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2395758

  • 21. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ.
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [Abstract] [Full Text] [Related]

  • 22. Comparison of oral erythromycin ethylsuccinate and ciprofloxacin in the treatment of acute respiratory tract infections.
    Feld MS, Carnegie C, Macklin J, Coles S.
    Br J Clin Pract; 1990 Oct; 44(10):404-8. PubMed ID: 2268518
    [Abstract] [Full Text] [Related]

  • 23. [Single dose therapy of uncomplicated urinary tract infections in women. Remission rates with ciprofloxacin in two prospective randomized comparative studies].
    Hoyme UB, Alimi M, Keuter U, Krasemann C, Krolla H, Moayer M, Philipps K, Pott E, Schindler AE, Yassin G.
    Fortschr Med; 1993 Jan 30; 111(3):45-8. PubMed ID: 8444395
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL, Figueroa-Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos-Fabra A, Amábile-Cuevas CF, Hernández-Oliva GM, Olguín J, Cardeñosa-Guerra O, uUTI Latin American Study Group.
    J Antimicrob Chemother; 2004 Oct 30; 54(4):840-3. PubMed ID: 15347634
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S, Galante D, Bianchi W, Gagliardi R.
    Am J Med; 1987 Apr 27; 82(4A):211-4. PubMed ID: 3555038
    [Abstract] [Full Text] [Related]

  • 28. [Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension].
    García Victor F, Ferrero Doria R.
    Arch Esp Urol; 2001 May 27; 54(4):313-20. PubMed ID: 11455764
    [Abstract] [Full Text] [Related]

  • 29. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O, Boratyńska M, Mróz E, Starek J.
    Pol Tyg Lek; 2001 May 27; 49(6-7):154-7. PubMed ID: 8090671
    [Abstract] [Full Text] [Related]

  • 30. Oral ciprofloxacin treatment of infections in geriatric patients.
    Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H.
    Clin Ther; 1989 May 27; 11(4):503-10. PubMed ID: 2776166
    [Abstract] [Full Text] [Related]

  • 31. Ciprofloxacin in the treatment of infections at different sites.
    Peralta S, Accursio A, Filaci G, Vitale B, D'Aiello G, Scarsi C, Collura D, Rini GB.
    J Chemother; 1989 Jul 27; 1(4 Suppl):674-5. PubMed ID: 16312587
    [No Abstract] [Full Text] [Related]

  • 32. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F, Cordón F, Gorina E, Caballero JC, Adalid C, Batlle J, Urinary Tract Infection Study Group.
    Clin Microbiol Infect; 2002 Jan 27; 8(1):50-4. PubMed ID: 11906502
    [Abstract] [Full Text] [Related]

  • 33. [3-day therapy of uncomplicated lower urinary tract infections using low-dose ciprofloxacin].
    Prát V, Horcicková M, Matousovic K, Hatala M, Milotová Z.
    Cas Lek Cesk; 1988 Nov 25; 127(48):1492-3. PubMed ID: 3242843
    [No Abstract] [Full Text] [Related]

  • 34. [Ciprofloxacin in the treatment of respiratory infections].
    Poggi F, Tognazzi F, Doddi M, Lauri A, Placidi C.
    Clin Ter; 1990 Jul 31; 134(2):111-7. PubMed ID: 2147611
    [Abstract] [Full Text] [Related]

  • 35. [A review of clinical studies on the efficacy and tolerance of intravenous ciprofloxacin].
    Memoli M.
    Recenti Prog Med; 1992 Jan 31; 83(1):27-34. PubMed ID: 1561480
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ.
    Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037
    [Abstract] [Full Text] [Related]

  • 37. Acute renal failure due to ciprofloxacin.
    Allon M, Lopez EJ, Min KW.
    Arch Intern Med; 1990 Oct 27; 150(10):2187-9. PubMed ID: 2222106
    [Abstract] [Full Text] [Related]

  • 38. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB, Pushkar' DIu, Rasner PI.
    Klin Med (Mosk); 2001 Oct 27; 79(12):35-8. PubMed ID: 11840809
    [Abstract] [Full Text] [Related]

  • 39. [Ciprofloxacin treatment in bacterial skin infections].
    Mohr CP, Küchmeister B, Reinel D, Ulrich R.
    Fortschr Med; 1989 May 30; 107(16):367-9. PubMed ID: 2737587
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.